There are many holy grails in the healthcare world: solving interoperability issues, achieving health equity and a universal patient record. Grail, the liquid biopsy company based in Menlo Park, California, is on another, equally challenging, quest: making sure fewer people die from cancer. Last June, the company introduced Galleri, a test that screens patients for more than 50 kinds of […]
